đ11 Kiryat Hamada Street, Jerusalem, Israel
|
|
|
|
|
|
Good Fences Make for Good Neighbors
The present newsletter addresses the way in which the monopolistic rights conferred by patent rights can be used for the good, as a way of both harmonizing technologies for the greater good, and by enabling an almost mentoring type of approach by large corporate patent holders to the start up sector. Even when zooming out globally, I briefly touch on the need to harmonize an approach when it comes to cross-border, distributed infringement. The current issue of our newsletter comes in the wake of the IPBC Asia conference in Tokyo which, as usual, provided an interesting insight into some of the main issues facing in-house practitioners in the tech sector, as 2024 reaches a close.
In the meantime, in the latest issue of our podcast, Avraham interviewed Sigal Kalmanson, CEO and founder of Starget Pharma, an Israeli early-stage clinical company developing a new class of Smart Targeted Radioligands for precision oncology of hard-to-heal cancers.
|
|
|
According to the Times Gazette, Benjamin Franklin wrote in the âPoor Richards Almanacâ âLove your neighbor as yourself, yet donât pull down your hedges.â This is based, of course, on the biblical passage âlove your fellow person as yourselfâ, and was the basis for the well-known passage in Robert Frostâs poem âNorth of Bostonâ in which he writes âMy apple trees will never get across and eat the cones under his pines, I tell him. He only says âGood fences make good neighborsâ.
Why is this relevant to IP? Iâll get to that later.
In the meantime, during a very intensive two daysâ worth of IP talks, panel discussions and round tables in Tokyo, I felt as if I was caught up in a whirlwind of IP heresy; subjects that threatened to shake the very foundations on which intellectual property rights are based. This happened during the November 2024 edition of the IPBC Asia conference, which I was privileged to attend, together with my colleague Dr. Mike Hammer.
|
|
|
Sigal Kalmanson is the CEO and founder of Starget Pharma, an Israeli early-stage clinical company developing a new class of Smart Targeted Radioligands for precision oncology of hard-to-heal cancers.
Avraham sat down with Sigal in the offices of Starget Pharma to discuss why Sigal started Starget, the role of IP in their business, how they got funded, how Sigal became the CEO, tips for startup founders and much more.
|
|
|
The JMB Davis Ben-David patent services team helps companies and individuals secure and leverage their patent rights for products in the US, Israel, and globally.
|
|
|
The JMB Davis Ben-David trademark services team works with leading international brands seeking to merchandize their products in the US, Israel and the rest of the world.
|
|
For 25 years, the JMB Davis Ben-David team has successfully assisted clients in registering design patents that protect their original designs for products ranging from medical devices to diamonds.
|
|
|
The JMB Davis
Ben-David
YouTube Channel
|
You'll find our hour long webinars on Patents and using the Patent system to your advantage.
|
|
|
|
|
|
We're here to help you with your patents, designs and trademarks.
|
We started JMB Davis Ben-David with one goal in mind: to help our clients navigate the challenges of securing rights to their IP. This includes patents, designs and trademarks. Since 1995 we have been working with partners around the world so as to secure our clientsâ IP rights. Weâre here for you.
|
Managing Partner
JMB Davis Ben-David
|
|
|
|
